Dosage form Design for Improvement of Bioavailability of Levodopa II: Bioavailability of Marketed Levodopa Preparations in Dogs and Parkinsonian Patients
- 1 March 1980
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 69 (3) , 261-265
- https://doi.org/10.1002/jps.2600690304
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Influence of route of administration on physiological availability of levodopa in dogsJournal of Pharmaceutical Sciences, 1976
- Intestinal Decarboxylation of Orally Administered L‐dopaActa Medica Scandinavica, 1975
- VARIATIONS IN L‐DOPA ABSORPTIONActa Medica Scandinavica, 1974
- Uptake and metabolism of l-3,4-dihydroxyphenylalanine (dopa) in rat tissuesBiochemical Pharmacology, 1973
- Intestinal decarboxylation of L-Dopa in relation to dose requirement in Parkinson's diseaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Decarboxylation of orally administered l-dopa in the human digestive tractNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1972
- l-3,4-dihydroxyphenylalanine metabolism by the GUT IN VITROBiochemical Pharmacology, 1971
- Absorption and Metabolism of L‐Dopa by the Human StomachEuropean Journal of Clinical Investigation, 1971
- Kinetics of Absorption and Excretion of Levodopa in DogsJournal of Pharmaceutical Sciences, 1971
- Preparation and properties of a homogeneous aromatic l-amino acid decarboxylase from hog kidneyArchives of Biochemistry and Biophysics, 1970